235 related articles for article (PubMed ID: 10436395)
1. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.
Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y
Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395
[TBL] [Abstract][Full Text] [Related]
2. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
Jayne DR; Esnault VL; Lockwood CM
J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Wegener's granulomatosis with intravenous immunoglobulin.
Richter C; Schnabel A; Csernok E; Reinhold-Keller E; Gross WL
Adv Exp Med Biol; 1993; 336():487-9. PubMed ID: 8296662
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.
Crickx E; Machelart I; Lazaro E; Kahn JE; Cohen-Aubart F; Martin T; Mania A; Hatron PY; Hayem G; Blanchard-Delaunay C; de Moreuil C; Le Guenno G; Vandergheynst F; Maurier F; Crestani B; Dhote R; Silva NM; Ollivier Y; Mehdaoui A; Godeau B; Mariette X; Cadranel J; Cohen P; Puéchal X; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
Arthritis Rheumatol; 2016 Mar; 68(3):702-12. PubMed ID: 26473632
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?
Aries PM; Hellmich B; Gross WL
Clin Rev Allergy Immunol; 2005 Dec; 29(3):237-45. PubMed ID: 16391399
[TBL] [Abstract][Full Text] [Related]
7. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.
Richter C; Schnabel A; Csernok E; De Groot K; Reinhold-Keller E; Gross WL
Clin Exp Immunol; 1995 Jul; 101(1):2-7. PubMed ID: 7621588
[TBL] [Abstract][Full Text] [Related]
8. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM
QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052
[TBL] [Abstract][Full Text] [Related]
10. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
Jordan SC; Toyoda M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.
Rossi F; Jayne DR; Lockwood CM; Kazatchkine MD
Clin Exp Immunol; 1991 Feb; 83(2):298-303. PubMed ID: 1993362
[TBL] [Abstract][Full Text] [Related]
12. A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
Levy Y; Sherer Y; Ahmed A; Langevitz P; George J; Fabbrizzi F; Terryberry J; Meissner M; Lorber M; Peter JB; Shoenfeld Y
Lupus; 1999; 8(9):705-12. PubMed ID: 10602441
[TBL] [Abstract][Full Text] [Related]
13. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of ANCA associated systemic necrotizing vasculitides].
Guillevin L
Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
Malenica B; Rudolf M; Kozmar A
Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Kallenberg CG
Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
[TBL] [Abstract][Full Text] [Related]
19. [Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].
Lamprecht P; Ahmadi-Simab K; Gross WL; Hellmich B
Med Klin (Munich); 2006 Mar; 101(3):212-25. PubMed ID: 16648979
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
